FHC Receives FDA Clearance to Market the Guideline 4000™  microrecording system

Bowdoin, Me. – July 27, 2007 -- FHC Inc. announced today that it has received clearance from U.S. Food and Drug Administration (FDA) to market its new Guideline 4000™ microrecording system for use in functional neurosurgical procedures where recording from and stimulation of the brain motor and sensory neurons will aid in the placement of depth electrodes.

The Guideline 4000™ microrecording system is designed for functional neurosurgery centers investigating and treating  single- and multi-target movement disorders.  Its versatile capabilities provide support for the use of up to ten microelectrodes simultaneously.  An additional four auxiliary analog input channels and two auxiliary digital input channels are also available.  Each microelectrode channel features optimized analog signal conditioning circuitry and a dedicated high speed digital signal processor allowing sophisticated real time analysis of the microelectrode signal. The Guideline 4000™ is a highly integrated system with built in audio monitoring, impedance checking, and both micro and macro stimulation capabilities available for all electrode channels at the push of a button.

November 15-19                  SFN Society for Neuroscience                      Washington, D.C.